Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study
Open Access
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 256, 47-52
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Current therapies for lowering lipoprotein (a)Journal of Lipid Research, 2016
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery diseaseNature Genetics, 2015
- Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in MenJACC, 2014
- Lipoprotein(a): resurrected by geneticsJournal of Internal Medicine, 2012
- The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetesEndocrine, 2012
- Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma VolumeJACC, 2008
- Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trialNutrition, 2008
- Physical Activity and Reduced Risk of Cardiovascular EventsCirculation, 2007
- Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric OxideCirculation, 2002
- EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer.1999